Tiziana Life Sciences Files Patent on Combination of Nanoparticle-Actinomycin D with Anti-Interleukin-6 Receptor Monoclonal Antibody for Treatment of Coronaviruses


You May Also Like

One World Play Project Debuts New Ways to Buy and Give

BERKELEY, Calif., Oct. 1, 2015 (GLOBE NEWSWIRE) -- Celebrating the company's 5th anniversary, One ...

Asterias Biotherapeutics to Present at Upcoming Conferences

FREMONT, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a ...